Search for: "Janssen Pharmaceuticals Inc." Results 121 - 140 of 247
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2013, 5:00 am
Janssen Pharmaceuticals, Inc., a New Jersey pharmaceutical company of J&J, provides medicines for attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
”J&J Subsidiary Janssen Pleads Guilty to Misbranding Antipsychotic DrugIn a criminal information filed today in the Eastern District of Pennsylvania, the government charged that, from March 3, 2002, through Dec. 31, 2003, Janssen Pharmaceuticals Inc., a J&J subsidiary, introduced the antipsychotic drug Risperdal into interstate commerce for an unapproved use, rendering the product misbranded. [read post]
4 Nov 2013, 3:04 am by Ben Vernia
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
7 Oct 2013, 7:12 am
Our next post will discuss the complimentary roles of inside and outside counsel. [1] Dura Pharmaceuticals, Inc. v. [read post]
7 Oct 2013, 7:12 am
Our next post will discuss the complimentary roles of inside and outside counsel. [1] Dura Pharmaceuticals, Inc. v. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
18 Jul 2013, 10:45 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals, 2013 WL 3480286 (Pa. [read post]
26 Jun 2013, 6:30 am by Gene Quinn
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
23 Jun 2013, 8:50 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:13-cv-01104; filed June 19, 2013 in the District Court of Delaware • Plaintiffs: Alza Corp.; Janssen Pharmaceuticals Inc. [read post]
1 Mar 2013, 6:28 am by Gene Quinn
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
31 Jan 2013, 7:30 am by Gene Quinn & Angel Krippner
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]